Benjamin Graham fit · Inversión deep-value defensiva
Is Iovance Biotherapeutics, Inc. Common Stock (IOVA) a Benjamin Graham Stock?
Meets only 3/7 Graham criteria — likely overpriced or unstable.
20/100
FNo encaja
3/7 criterios cumplidos
Los criterios de Benjamin Graham, aplicados a IOVA
P/E ≤ 15
clave—
P/B ≤ 1.5
clave0.0x
Current ratio ≥ 2
3.4x
Debt / Equity ≤ 1
0.0x
Cómo se valora IOVA en otras estrategias
Datos financieros en vivo
Cap. mercado
$1.47B
PER (TTM)
-
ROIC (TTM)
-45.33%
Margen bruto
-
Otros análisis Benjamin Graham
Preguntas frecuentes
What is IOVA's Benjamin Graham fit score?
IOVA scores 20/100 on our Benjamin Graham fit engine — grade F. Meets only 3/7 Graham criteria — likely overpriced or unstable.
Does Benjamin Graham actually own IOVA?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends IOVA.
How often is this score updated?
IOVA's Benjamin Graham fit score is recomputed daily from the latest TTM financials.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Benjamin Graham posea o recomiende IOVA personalmente.